Share

September 24, 2019; 93 (13) Clinical/Scientific Notes

Dravet syndrome and parkinsonism

A case report investigating the dopaminergic system

Lisa Deuel, Abigail E. Collins, Edward H. Maa, Jessica P. Barr, Drew S. Kern
First published August 23, 2019, DOI: https://doi.org/10.1212/WNL.0000000000008171
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
201

Share

Article Information

vol. 93 no. 13 595-596
DOI: 
https://doi.org/10.1212/WNL.0000000000008171
PubMed: 
31444242
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received February 8, 2019
  • Accepted in final form June 26, 2019
  • First Published August 23, 2019.

Article Versions

Copyright & Usage: 
© 2019 American Academy of Neurology

Author Disclosures

    1. Lisa Deuel, MD,
    2. Abigail E. Collins, MD,
    3. Edward H. Maa, MD,
    4. Jessica P. Barr, PA and
    5. Drew S. Kern, MD, MS
  1. Lisa Deuel, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Abigail E. Collins, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Bracket Global, Inc. consulting payments for speaking at IM and input regarding ongoing studies Ultragenyx Pharma, consulting for speaking at IM

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Bracket Global, Inc Ultragenyx Pharma, Inc

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Edward H. Maa, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Speakers Bureau activity for GW Pharma are directed to the Denver Health Foundation. No speaking engagements have been scheduled to date.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. 1. GW Pharma (commercial)

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Jessica P. Barr, PA and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Was part of a medical board in 2018 for CLES (Carbidopa levodopa enteral suspension)for Parkinson disease for Abbvie.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Drew S. Kern, MD, MS
    6. Scientific Advisory Boards:

    1. Drew Kern has served as an advisor for Colorado Clinical and Translational Sciences Institute (CCTSI) Data Safety Monitoring Board, Knoebel Institute for Healthy Aging, Michael J. Fox Foundation and AbbVie Pharmaceutics

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. received honorarium from Merz Pharma and AbbVie Pharmaceutics

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. received grants from the Parkinson?s Society of Canada, University of Colorado Skin Disease Research Center and National Institutes of Health.

    Research Support, Academic Entities:

    1. Employed by the University of Colorado

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (L.D., E.H.M., J.P.B., D.S.K.), University of Colorado School of Medicine, Aurora, CO; Department of Pediatrics (A.E.C.), Section of Neurology, University of Colorado School of Medicine, Aurora, CO; Department of Neurosurgery (DSK), University of Colorado School of Medicine, Aurora, CO.
  1. Correspondence
    Dr. Kern drew.kern{at}ucdenver.edu
View Full Text

Article usage

Article usage: August 2019 to February 2023

AbstractFullPdfSource
Aug 2019365025Highwire
Sep 20194095642Highwire
Oct 20191701818Highwire
Nov 20198034Highwire
Dec 20194439Highwire
Jan 202056104Highwire
Feb 20207956Highwire
Mar 20201381315Highwire
Apr 20204454Highwire
May 20203721Highwire
Jun 20204030Highwire
Jul 20206950Highwire
Aug 20204010Highwire
Sep 20204054Highwire
Oct 20206922Highwire
Nov 20204523Highwire
Dec 20204311Highwire
Jan 20215212Highwire
Feb 20214731Highwire
Mar 20214453Highwire
Apr 20212201Highwire
May 20214223Highwire
Jun 20213204Highwire
Jul 20215324Highwire
Aug 20214525Highwire
Sep 20212322Highwire
Oct 20212303Highwire
Nov 20212713Highwire
Dec 20212900Highwire
Jan 20221211Highwire
Feb 20223501Highwire
Mar 20223000Highwire
Apr 20223014Highwire
May 20222401Highwire
Jun 20222802Highwire
Jul 20221315Highwire
Aug 20225813Highwire
Sep 20223010Highwire
Oct 2022801Highwire
Nov 20224216Highwire
Dec 20221432Highwire
Jan 20231904Highwire
Feb 20232622Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles